Director

Dr. Manish Sadarangani

Dr. Manish Sadarangani

Investigator, BC Children's Hospital
Sauder Family Chair in Pediatric Infectious Diseases, University of British Columbia
Associate Professor, Department of Pediatrics, Faculty of Medicine, University of British Columbia

Dr. Sadarangani began the role of VEC Director in 2016. He joined the VEC from The Children's Hospital in Oxford, UK, where he was a Clinical Lecturer and Consultant in Pediatric Infectious Diseases and Immunology. Dr. Sadarangani plans to build a research program that incorporates laboratory, clinical and population-based studies. His work will include studying the relationships between bowel bacteria and responses to infant vaccines, as increasing evidence points to "good germs" being able to strengthen immunity. The ultimate goal of his research is to inform evidence-based policy to lower the burden of childhood infectious diseases through vaccination.

Investigators

Dr. David Scheifele

Dr. David Scheifele

Investigator, BC Children's Hospital
Professor Emeritus, Division of Infectious and Immunological Diseases, Department of Pediatrics, Faculty of Medicine, University of British Columbia

Dr. Scheifele is one of the original founders of the VEC and was the VEC Director from 1988-2016. In 2012, he was appointed as an Officer of the Order of Canada in recognition of his outstanding contributions to the prevention of infections in children. Dr. Scheifele is a pediatric infectious disease specialist and his many interests include the prevention of influenza, haemophilus influenzae type b infections (which cause meningitis), pneumococcal infections, and vaccine safety.

Dr. Julie Bettinger

Dr. Julie Bettinger

Investigator, BC Children's Hospital
Associate Professor, Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, University of British Columbia

Dr. Bettinger is an Associate Professor at the VEC in the Department of Pediatrics at the University of British Columbia and a Michael Smith Foundation for Health Research Scholar. Her research interests include vaccine safety and vaccine preventable diseases as well as attitudes and beliefs around immunization uptake and use. She is the epidemiologist for the Canadian Immunization Monitoring Program, Active (IMPACT), an active surveillance network for vaccine preventable diseases and vaccine adverse events in 12 tertiary care pediatric hospitals across Canada and the lead investigator for PCIRN's National Ambulatory Network.

Dr. Tobias Kollmann

Dr. Tobias Kollmann

Affiliate Investigator, BC Children's Hospital
Pediatric Infectious Disease Consultant, BC Children's Hospital
Senior Clinician Scientist, BC Children's Hospital Research Institute
Affiliate Professor, Infectious and Immunological Diseases, Department of Pediatrics, Faculty of Medicine, University of British Columbia

Dr. Kollmann joined the VEC in 2006. As a pediatric infectious disease specialist, his main research interest is to learn how the newborn's immune system works to prevent infections during this vulnerable time period. His goal is to find ways to improve the immune response that babies have to vaccines to provide them with better protection.

Dr. Soren Gantt

Dr. Soren Gantt

Investigator, BC Children's Hospital
Pediatric Infectious Disease Specialist, BC Children's Hospital
Director, Clinical Research, BC Children's Hospital
Associate Professor, Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, University of British Columbia

Dr. Gantt joined the VEC in 2012. He is a Senior Associate Clinician Scientist at the VEC and an Associate Professor at the University of British Columbia. His current research focus includes Herpesvirus infection (HHV), HIV, cancer, antiviral, and immune response. His goals are to address fundamental questions about how to prevent and treat HHV-related diseases, including a focus on HHV infections early in life and in utero.

Dr. Laura Sauvé

Dr. Laura Sauvé

Investigator, BC Children's Hospital
Clinical Assistant Professor, Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, University of British Columbia

Dr. Sauvé joined the VEC in 2007. She is a pediatric infectious disease specialist who has a special interest in Pediatric HIV. Her main research interests include vaccine preventable disease, global child health and pediatric HIV. She is the BC site investigator for the Immunization Monitoring Program, Active, a national surveillance system for vaccine preventable diseases and vaccine adverse events in 12 pediatric tertiary care centers across Canada. She also is the co-primary investigator of the Canadian Perinatal HIV Surveillance Program, which studies vertical transmission of HIV across Canada.

Dr. Ali Harandi

Dr. Ali Harandi

Visiting Associate Professor

Dr. Harandi is an Associate Professor in Clinical Immunology at the University of Gothenburg, Sweden, and a visiting Associate Professor at the VEC, Department of Peadiatrics, BCCHR, The University of British Columbia. He serves in the leadership of several EU/international projects on vaccine R&D, and also serves as an advisor to several non-profit research organizations. His main research goal is to characterize protective immune responses induced by vaccines and mucosal infections in humans.

Research Associates

Dr. James Zlosnik

Dr. James Zlosnik

Research Associate, Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, University of British Columbia; Co-director, Canadian Burkholderia cepacia complex research and referral repository.

Dr. Zlosnik joined UBC in 2006 and is an infectious disease microbiologist.   He is co-director, along with Dr. Sadarangani and Dr. Mark Chilvers (Director of the Pediatric Cystic Fibrosis Clinic), of the Canadian Burkholderia cepacia complex research and referral repository - which is a national resource for hospitals and CF clinics to obtain accurate bacterial identifications.  Dr Zlosnik's research ranges from the molecular level (DNA sequencing, molecular genetics, proteomics and application of bioinformatics) to phenotype based laboratory studies through to population biology (epidemiology and clinical research).  His goals are to better understand the microbial component of infectious diseases such that continued improvements can be made to treatment and the lives of people affected.

Learn more about the VEC Team

Research Fellows & Students

Research Support